- Home
- LXRX vs SKYX Comparison
LXRX vs SKYX Comparison
Compare LXRX & SKYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- SKYX
- Stock Information
- Founded
- LXRX 1995
- SKYX 2004
- Country
- LXRX United States
- SKYX United States
- Employees
- LXRX N/A
- SKYX N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- SKYX Building Products
- Sector
- LXRX Health Care
- SKYX Consumer Discretionary
- Exchange
- LXRX Nasdaq
- SKYX Nasdaq
- Market Cap
- LXRX 124.4M
- SKYX 121.0M
- IPO Year
- LXRX 2000
- SKYX 2022
- Fundamental
- Price
- LXRX $0.46
- SKYX $1.14
- Analyst Decision
- LXRX Buy
- SKYX Strong Buy
- Analyst Count
- LXRX 4
- SKYX 3
- Target Price
- LXRX $3.67
- SKYX $4.00
- AVG Volume (30 Days)
- LXRX 30.7M
- SKYX 407.1K
- Earning Date
- LXRX 03-06-2025
- SKYX 03-24-2025
- Dividend Yield
- LXRX N/A
- SKYX N/A
- EPS Growth
- LXRX N/A
- SKYX N/A
- EPS
- LXRX N/A
- SKYX N/A
- Revenue
- LXRX $31,081,000.00
- SKYX $86,276,876.00
- Revenue This Year
- LXRX N/A
- SKYX $38.07
- Revenue Next Year
- LXRX $101.91
- SKYX $20.22
- P/E Ratio
- LXRX N/A
- SKYX N/A
- Revenue Growth
- LXRX 2481.48
- SKYX 46.77
- 52 Week Low
- LXRX $0.28
- SKYX $0.72
- 52 Week High
- LXRX $2.45
- SKYX $2.14
- Technical
- Relative Strength Index (RSI)
- LXRX 50.12
- SKYX 38.32
- Support Level
- LXRX $0.32
- SKYX $1.15
- Resistance Level
- LXRX $0.41
- SKYX $1.45
- Average True Range (ATR)
- LXRX 0.05
- SKYX 0.11
- MACD
- LXRX 0.03
- SKYX 0.01
- Stochastic Oscillator
- LXRX 36.36
- SKYX 12.86
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
About SKYX SKYX Platforms Corp.
SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. The company's technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post and is capable of feeding electric power to an appliance. The Company generates its income from the United States.